\n\n\n\n\t\t\n\t\t\tSequel Pharmaceuticals\n\t\t\thttp://www.sequelpharma.com/\n\t\t
\n\t\t\n\t\t\tWatch Company\n\t\t\tGet Widget\n\t\t
\n\tSequel Pharmaceuticals is a product-focused pharmaceutical company with significant capabilities and experience in cardiovascular drug development. The company is committed to improving the quality of...More»
\n\t\t\tSequel Pharmaceuticals is a product-focused pharmaceutical company with significant capabilities and experience in cardiovascular drug development. The company is committed to improving the quality of care for patients with cardiovascular disease by developing and commercializing novel, clinical-stage drug candidates. Sequel intends to grow its drug portfolio through in-licensing of additional cardiovascular drug candidates.«Less
\n\n\t\t\tOverview
\n\t\t\t\tLocation: \tSan Diego, CA, United States\n
\n\t\t\t\tIndustry: Biopharmaceuticals
\n\t\t\t\tTags:\n\t\t\t\tproduct,\n\t\t\t\tmedical,\n\t\t\t\tsequel,\n\t\t\t\tdrug,\n\t\t\t\tpharmaceuticals,\n\t\t\t\tclinical,\n\t\t\t\tHealthcare,\n\t\t\t\tcardiovascular\n\t\t\t\t
\n\t\t\tFinancials
\n\t\t\t\tLatest Funding: Series A - $20M (09/2007)
\n\t\t\t\tInvestors:\n\t\t\t\t\t\n\t\tDomain Associates,\n\t\t\t\t\t\n\t\tForward Ventures,\n\t\t\t\t\t\n\t\tInterWest Partners,\n\t\t\t\t\t\n\t\tMontreux Equity Partners,\n\t\t\t\t\t\n\t\tSkyline Ventures\n\t\t\t\t
\n\t\t\tMarket
\n\n\t\t\t\tRelated Companies:\n\t\t\t\t\tCelator Pharmaceuticals,\n\t\t\t\t\tVentiRx,\n\t\t\t\t\tCadence Pharmaceuticals,\n\t\t\t\t\tVanda Pharmaceuticals,\n\t\t\t\t\tAffymax,\n\t\t\t\t\tTragara Pharmaceuticals,\n\t\t\t\t\tComGenex International,\n\t\t\t\t\tPhysiogenix Preclinical Services,\n\t\t\t\t\tAnthera Pharmaceuticals,\n\t\t\t\t\tOthera Pharmaceuticals\n\t\t\t\t
\n\t\t\t